NEONC Technologies

NEONC Technologies is a medical biotechnology company focused on creating new delivery methods for pharmaceutical-based therapies targeting brain and central nervous system (CNS) diseases. Established in 2008, the company has developed a unique molecular packaging technology capable of efficiently delivering therapeutic agents directly to the brain, bypassing the normal boundary restrictions imposed by the human blood-brain barrier (BBB). As a result, pharmaceutical companies whose CNS therapies may have achieved limited success due to current delivery constraints will now be able to provide patients with more effective treatments.